Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▾	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
IRD	Opus Genetics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.20M	-$49.59M	-349.3%	-323.1%	29.1%	-$0.80
ABUS	Arbutus Biopharma Corp Manufacturing · Year ended 2025-12-31 · USD	$14.08M	-$33.50M	-237.9%	-43.7%	128.2%	-$0.17
PYXS	Pyxis Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.86M	-$79.62M	-574.5%	-149.1%	-14.2%	-$1.28
CVSI	CV Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.79M	-$958.0K	-6.9%	-65.3%	-12.2%	-$0.01
TNXP	Tonix Pharmaceuticals Holding Corp. Manufacturing · Year ended 2025-12-31 · USD	$13.11M	-$124.02M	-946.2%	-50.6%	29.8%	-$14.57
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22
EMMA	Emmaus Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$12.45M	-$7.49M	-60.2%	n/a	-25.2%	-$0.12
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
JAGX	Jaguar Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.51M	-$53.58M	-465.4%	n/a	-1.5%	-$22.97
CBIO	Crescent Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.84M	-$153.94M	n/m	-75.8%	n/a	n/a
JANX	Janux Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$113.62M	n/m	-11.9%	-5.6%	-$1.83
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
PGEN	Precigen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$250.64M	n/m	n/m	146.7%	-$1.37
PRTA	Prothena Corp Public Ltd Co Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$244.09M	n/m	-87.0%	-92.8%	-$4.53
ISCO	International Stem Cell Corp Manufacturing · Year ended 2025-12-31 · USD	$9.10M	-$418.0K	-4.6%	n/a	0.2%	-$0.05
BIOA	BioAge Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$8.99M	-$80.61M	-896.1%	-29.6%	n/a	-$2.24
ROIV	Roivant Sciences Ltd. Manufacturing · Year ended 2026-03-31 · USD	$8.26M	-$299.77M	n/m	-6.6%	-71.6%	-$0.54
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
BOLT	Bolt Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.70M	-$33.38M	-433.7%	-125.9%	0.1%	-$17.85
ADAG	Adagene Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.67M	-$17.61M	-229.6%	-49.8%	n/m	-$0.30
XENE	Xenon Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.50M	-$345.91M	n/m	-59.5%	n/a	-$4.36
OVID	Ovid Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.25M	-$17.41M	-240.1%	-13.3%	n/m	n/a
WHWK	Whitehawk Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.14M	-$20.60M	-288.3%	-15.1%	-72.5%	-$0.33
IMNM	Immunome Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.94M	-$212.39M	n/m	-33.5%	-23.2%	-$2.43

Rows per page: 2550 100